Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Intra-Cellular Therapies	Supernus Pharmaceuticals	Y-mAbs Therapeutics	IGM Biosciences	Rocket Pharmaceuticals
Symbol	NASDAQ:ITCI	NASDAQ:SUPN	NASDAQ:YMAB	NASDAQ:IGMS	NASDAQ:RCKT
Price Information
Current Price	$15.48	$18.30	$26.00	$58.92	$14.72
52 Week Range	Buy	Buy	Buy	Buy	Buy
Analyst Ratings
Consensus Recommendation	Buy	Buy	Buy	Buy	Buy
Consensus Price Target	$37.13	$43.80	$39.50	$35.00	$38.67
% Upside from Price Target	139.83% upside	139.34% upside	51.92% upside	-40.60% downside	162.68% upside
Trade Information
Market Cap	$843.49 million	$938.71 million	$940.64 million	$1.83 billion	$810.63 million
Beta	1.99	1.49	1.13	N/A	2.6
Average Volume	1,383,023	616,949	224,332	138,511	427,393
Sales & Book Value
Annual Revenue	$60,000.00	$392.76 million	N/A	N/A	N/A
Price / Sales	14,298.10	2.45	N/A	N/A	N/A
Cashflow	N/A	$2.64 per share	N/A	N/A	N/A
Price / Cash	N/A	6.93	N/A	N/A	N/A
Book Value	$3.52 per share	$11.35 per share	$5.01 per share	$7.88 per share	$6.10 per share
Price / Book	4.40	1.61	N/A	N/A	N/A
Profitability
Net Income	$-147,720,000.00	$113.06 million	$-81,030,000.00	$-43,130,000.00	$-77,270,000.00
EPS	($2.68)	$2.10	($2.30)	($4.80)	($1.58)
Trailing P/E Ratio	N/A	8.67	N/A	N/A	N/A
Forward P/E Ratio	N/A	12.98	N/A	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	28.78%	N/A	N/A	N/A
Return on Equity (ROE)	-61.09%	20.98%	-62.48%	N/A	-32.04%
Return on Assets (ROA)	-49.88%	10.38%	-55.30%	N/A	-25.27%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.10%	0.63%	0.01%	0.05%	0.15%
Current Ratio	6.36%	2.94%	15.60%	26.04%	16.81%
Quick Ratio	6.36%	2.78%	15.60%	26.04%	16.81%
Ownership Information
Institutional Ownership Percentage	68.63%	97.63%	48.55%	40.89%	94.35%
Insider Ownership Percentage	18.20%	6.57%	38.40%	N/A	41.40%
Miscellaneous
Employees	73	448	32	40	33
Shares Outstanding	55.42 million	52.53 million	39.76 million	30.56 million	55.07 million
Next Earnings Date	5/13/2020 (Estimated)	5/5/2020 (Estimated)	5/8/2020 (Estimated)	6/25/2020 (Estimated)	5/13/2020 (Estimated)
Optionable	Optionable	Optionable	Not Optionable	Not Optionable	Optionable

Comparison Ideas:

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

Start Your Free Trial Today

Market Data and Calendars

Investing Education and Resources